Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationGraft vs Host DiseaseTransplantation, AutologousTransplantation ConditioningHematologic NeoplasmsHematopoietic Stem Cell MobilizationGranulocyte Colony-Stimulating FactorTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanAntigens, CD34Immunosuppressive AgentsTreatment OutcomeLeukapheresisBone MarrowVidarabineRecurrenceBone Marrow CellsWhole-Body IrradiationHematopoietic Stem CellsLeukemiaHistocompatibilityHistocompatibility TestingGraft vs Leukemia EffectStem Cell TransplantationStem CellsSurvival AnalysisRetrospective StudiesCyclophosphamideCombined Modality TherapyBlood Component RemovalMelphalanMyeloablative AgonistsAnemia, AplasticAntineoplastic Combined Chemotherapy ProtocolsChronic DiseaseMultiple MyelomaBone Marrow PurgingLymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-LymphomaDisease-Free SurvivalRemission InductionHematopoiesisT-LymphocytesCord Blood Stem Cell TransplantationTime FactorsTransplantation, IsogeneicHLA AntigensBlood CellsBone and BonesCytomegalovirus InfectionsTransplantation ImmunologyLeukemia, Myeloid, AcuteEtoposideBone Marrow DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood Cell CountSurvival RateCyclosporineLymphocyte DepletionLeukocyte TransfusionKidney TransplantationHematologic DiseasesFlow CytometryAcute DiseaseImmunosuppressionInfectionLiver TransplantationOpportunistic InfectionsNeoplasmsSalvage TherapyLymphocyte TransfusionAntineoplastic Agents, AlkylatingCytarabineTransplantationFollow-Up StudiesMyelodysplastic SyndromesThiotepaHodgkin DiseaseMice, Inbred C57BLColony-Forming Units AssayImmunocompromised HostLeukemia, MyeloidGraft RejectionLymphomaRecombinant ProteinsHepatic Veno-Occlusive DiseaseCell DifferentiationLeukocyte CountCell SeparationBlood DonorsFatal OutcomeImmunophenotypingPlatelet CountCells, CulturedCarmustine